Updates
This is in continuation to our letter dated August 11, 2017, in the matter relating to M/s Daiichi Sankyo Company Limited v/s Oscar Investments Limited & Others, the Hon'ble Supreme Court of India today clarified that the directions relating to maintaining status quo with regards to the holding of Fortis Healthcare Holding Private Limited (FHHPL), a Promoter Group Entity, in the Company applies to both the encumbered and unencumbered shares.... Updates
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the Company has today sold off its entire stake in M/s. Fortis Medicare International Limited, an associate company to M/s. Fortis Global Healthcare Private Limited, a promoter group company. The detailed disclosure as required under Regulation 30 is attached herewith. This is for your kind information and records purposes. Notice Of 21St Annual General Meeting.
Dear Sirs, Pursuant to the provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached the notice for convening 21st Annual General Meeting of Fortis Healthcare Limited, scheduled to be held on Tuesday, September 26, 2017 at 1200 Noon at National Institute of Pharmaceutical Education and Research Mohali, Sector 67, SAS Nagar, Mohali. This is for your information and records please. Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Fortis Healthcare Holdings Pvt Ltd Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Fortis Healthcare Holdings Pvt Ltd Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Fortis Healthcare Holdings Pvt. Ltd. Why big investors, brokerages like Fortis Healthcare
The Fortis Healthcare stock was up 8 per cent after buy ratings from brokerages and on news that Rakesh Jhunjhunwala picked up a stake in the company on Tuesday. For a company whose stock has taken a beating - down almost a third per cent in about three months, due to issues at the promoter group that have little direct impact for Fortis, these latest developments are a welcome. So, why this positive stance on Fortis?Goldman Sachs, which has a buy rating on the company, believes the mature hospitals and better occupancies will lead to margin expansion to the tune of 280 basis points during the FY18-20 period. Flagship hospitals will drive revenues, which is pegged to grow at 11 per cent annually over the same period. Other analysts expect its revenues to grow by about 10 per cent annually led by higher volumes as well as better product (specialty) mix. About 80 per cent of the company's owned beds are five years old, which coupled with occupancies in excess of 60 per cent translates .. Fortis Health surges after Jhunjhunwala buys shares
The shares were purchased on an average price of Rs 134.65, valuing the transaction at Rs 60.59 crore. Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Fortis Healthcare Holdings Pvt Ltd Updates
Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, this is to inform you that the Fortis Cancer Care Limited ('FCCL'), a step down subsidiary of the Company has entered into a memorandum of understanding ('MoU') with Lalitha Healthcare Private Limited ('LHPL'), another step down subsidiary of the Company, Dr. Lakshmi Narayana Raju, Ms. Lakshmi Priya, Mr. S. Venkataramana Raju (collectively the 'Promoters of LHPL') and Anikrish Hospitals...